Literature DB >> 19568145

Pediatric thermal injury: acute care and reconstruction update.

Alexis D Armour1, David A Billmire.   

Abstract

BACKGROUND: The acute and reconstructive care of each pediatric burn patient presents unique challenges to the plastic surgeon and the burn care team.
METHODS: : The purpose of this review article is to highlight the interdependence between the acute and reconstructive needs of pediatric burn patients as it pertains to each anatomical site. Relevant principles of acute pediatric burn care and burn reconstruction are outlined, based on the authors' experience and review of the literature.
RESULTS: The need for late reconstruction in pediatric burn survivors is significantly influenced by the acute surgical and rehabilitative treatments. With their vulnerability to airway swelling, hypothermia, pulmonary edema, and ischemia-reperfusion injury, pediatric patients with large burns require precise, life-saving treatment in the acute phase. Decision-making in pediatric burn reconstruction must take into account the patient's future growth, maturity, and often lack of suitable donor sites.
CONCLUSION: Appropriately selected reconstructive techniques are essential to optimize function, appearance, and quality of life in pediatric burn survivors.

Entities:  

Mesh:

Year:  2009        PMID: 19568145     DOI: 10.1097/PRS.0b013e3181a80763

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  2 in total

1.  Rapid enzymatic burn debridement: A review of the paediatric clinical trial experience.

Authors:  Yaron Shoham; Yuval Krieger; Guy Rubin; Ingo Koenigs; Bernd Hartmann; Frank Sander; Alexandra Schulz; Keren David; Lior Rosenberg; Eldad Silberstein
Journal:  Int Wound J       Date:  2020-05-22       Impact factor: 3.315

2.  Extended lower trapezius myocutaneous flap in burn scar reconstruction of the face and neck of children.

Authors:  Xing-Yue Zheng; Xin Guo; Tai-ling Wang; Jia-Qi Wang
Journal:  Pediatr Surg Int       Date:  2011-08-06       Impact factor: 1.827

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.